Home
Advertisement & Sponsorship Options
Download Our Media Kit
Changing Physician Behavior
Cancer A – Z
Drug Developmemt Technologies
A Novel Technology based on Somatic Hypermutation (SHM)
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
The Network
The Episodes
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
The Onco’Zine Brief
The Episodes
National Advertising
Resources
Membership
Agenda
Join Today
Video
Careers
SABCS and ASH 2023
Search
About
Advertise
Advisory Board
Contact Us
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Onco'Zine
Advertisement #1
Home
Advertisement & Sponsorship Options
Download Our Media Kit
Changing Physician Behavior
Cancer A – Z
Drug Developmemt Technologies
A Novel Technology based on Somatic Hypermutation (SHM)
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
The Network
The Episodes
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
The Onco’Zine Brief
The Episodes
National Advertising
Resources
Membership
Agenda
Join Today
Video
Careers
SABCS and ASH 2023
Home
Tags
Pembrolizumab
Tag: pembrolizumab
Combination of Adagrasib and Pembrolizumab in First-Line Non-Small Cell Lung Cancer...
Editorial Team
-
October 22, 2023
Improving Clinical Trials with a Simpler and More Inclusive Study Design
Editorial Team
-
April 21, 2023
Keynote-966: Pembrolizumab + Chemotherapy May Benefit Patients with Advanced Biliary...
Editorial Team
-
April 16, 2023
mRNA Cancer Vaccine + Immunotherapy Prolongs Improves Survival in High-risk Melanoma
Danielle Garcia
-
April 16, 2023
UK Cancer Patients to Receive the First Immunotherapy for Advanced Cervical...
Editorial Team
-
March 30, 2023
Pfizer Agrees to Acquire Seagen for US $ 43 Billion
Editorial Team
-
March 13, 2023
Cabozantinib + Pembrolizumab Shows ORR of 54% in Treatment of Recurrent or...
Danielle Garcia
-
June 4, 2022
Combination Trials with Immune Checkpoint Inhibitors may not Result in Synergistic...
Editorial Team
-
February 28, 2022
Pembrolizumab Shows Significantly Prolonged Event-free Survival in High-Risk Early-Stage TNBC
Editorial Team
-
February 9, 2022
The Path Toward Curative Treatments in Cervical Cancer
Jennifer Buell, Ph.D.
-
October 18, 2021
1
2
3
...
5
Page 1 of 5
LATEST NEWS
Drug Combination Shows Promise in Treatment of Nerve Sheath Tumors
Editorial Team
-
December 1, 2023
Genomic Nasal Swab Test may Improve Lung Cancer Risk Assessment for Smokers with Lung...
Editorial Team
-
November 30, 2023
Preoperative Intravenous Iron Reduces the Need for Blood Transfusion in Colorectal Cancer Surgery
Peter Hofland
-
November 25, 2023
Are The Catholic Church and Its Hospitals A Marriage Made in Heaven?
Editorial Team
-
November 24, 2023
Microbubbles: The Unlikely Key to Providing Accessible and Effective Cancer Treatments
Brandon H. McNaughton, Ph.D.
-
November 23, 2023
X